Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study (Q36633637)
Jump to navigation
Jump to search
scientific article published on 24 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study |
scientific article published on 24 May 2012 |
Statements
1 reference
Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study (English)
1 reference
Bertrand Guidet
1 reference
Olivier Martinet
1 reference
Thierry Boulain
1 reference
Francois Philippart
1 reference
Jean François Poussel
1 reference
Julien Maizel
1 reference
Xavier Forceville
1 reference
Marc Feissel
1 reference
Michel Hasselmann
1 reference
Alexandra Heininger
1 reference
Hugo Van Aken
1 reference
24 May 2012
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference